Search results
Results From The WOW.Com Content Network
A 2017 review found that people with diabetes who were taking metformin had lower all-cause mortality. They also had reduced cancer and cardiovascular disease compared with those on other therapies. [219] In people without diabetes, metformin does not appear to reduce the risk of cancer and cardiovascular disease. [224]
Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. [ 1][ 2] It is regarded as a second-line option compared to metformin, due to metformin's well-established safety and efficacy. [ 1] Use of glimepiride is recommended in conjunction with lifestyle modifications ...
In the United States, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [5] [6]In the European Union, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in people with type 2 diabetes; in combination with a sulfonylurea as an adjunct to diet and exercise "in people ...
Metformin's prescribing information indicates diarrhea as a common side effect. Up to 53% who take metformin will have diarrhea. Up to 46% of people who take metformin will stop taking the ...
03:31. Another study is raising concern about the safety of the widely used sugar alcohol sweetener erythritol, a low-calorie sugar substitute found in “keto-friendly” foods, baked goods and ...
Sulfonylurea type 2 diabetes drugs are linked to a higher long-term risk of an impaired awareness of hypoglycemic episodes, according to a new study from Taiwan. From 5 years of use onward, the ...
Canagliflozin/metformin is indicated in adults aged 18 years of age and older with type 2 diabetes as an adjunct to diet and exercise to improve glycemic control. [1] [2] [3] Adverse effects [ edit ]
The Biden administration on Thursday announced Medicare negotiated discounts with pharmaceutical companies on 10 drugs prescribed to treat blood clots, cancer, heart disease, and diabetes. The ...